Yasuo Fujii, MD, PhD, is affiliated with Yamanashi Prefectural Kita Hospital in Yamanashi, Japan. Fujii has published research on schizophrenia and schizoaffective disorders, with a focus on tardive dyskinesia and metabolic side effects associated with antipsychotic treatments. The work includes analyses of long-acting injectable antipsychotics and the incidence of hyperglycemia in patients treated with olanzapine. Fujii's publications span from 2004 to 2022 and appear in Psychiatrist.com journals.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
